Carboxypeptidase A1 (Pancreatic) (CPA1) Peptide
CPA1
Reactivity: Human
Host: Synthetic
BP, WB
Catalog No. ABIN975227
Quick Overview for Carboxypeptidase A1 (Pancreatic) (CPA1) Peptide (ABIN975227)
Target
CPA1
(Carboxypeptidase A1 (Pancreatic) (CPA1))
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-CPA1 antibody (Catalog #: ARP33859_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- CPA1 (Carboxypeptidase A1 (Pancreatic) (CPA1))
-
Background
-
Three different forms of human pancreatic procarboxypeptidase A have been isolated. The A1 and A2 forms are monomeric proteins with different biochemical properties. Carboxypeptidase A1 is a monomeric pancreatic exopeptidase. It is involved in zymogen inhibition.
Alias Symbols: CPA
Protein Size: 419 -
Molecular Weight
- 47 kDa
-
Gene ID
- 1357
-
NCBI Accession
- NM_001868, NP_001859
-
UniProt
- P15085
Target
-
You are here:
